Danskerne er blevet mere positive overfor sundhedsteknologiske løsninger, siden Danmark lukkede ned den 11. marts for at stoppe smittespredning med coronavirus.
Selvom Det Europæiske Institut for Innovation og Teknologi skyder milliarder af euro i lovende projekter, dominerer amerikanerne og kineserne stadigvæk listen over såkaldte unicorns.
Allergikoncernen ALK tjener ikke kun penge på allergibehandlinger, for millioner af kroner strømmer også ind fra onlinesalg af forbrugerprodukter som saltinhalatorer og fysisk blokerende næsesprays. Selskabets consumer care-division kan blive lige så stort som ALKs kernemarked, allergimedicin, lyder det fra den adm. direktør.
E-health-selskabet Dawn Health nedsætter nu en professionel bestyrelse for blandt andet at skalere forretningen til fortsat ekspansion mod udlandet. Første eksterne bestyrelsesmedlem er hentet hos Demant.
Den amerikanske producent af høreapparater Starkey går sammen med et israelsk firma, der står bag udstyr til personer med synsbesvær. Sammen lancerer de som de første i verden et produkt, der med brug af krustig intelligens og på en og samme gang kan hjælpe mod både syns- og hørehandicap.
Vice President Global Quality Assurance and Regulatory Affairs – Etac Group 
Trial Project Manager to lead global clinical trials in a time of great change - Novo Nordisk 
Director of Clinical Quality Assurance Operations – Orphazyme 
Global Sales Manager – MC2 Therapeutics 
Director Pharmacology & New Target Discovery - Y-mAbs 
Senior Scientist in Molecular Pharmacology - Zealand Pharma Senior Manager, Master Planner - Orphazyme 
Kvalitetschef, QP/RP til Specific Pharma A/S Manager of Medical Writing - Orphazyme 
Regulatory Manager – Thermo Fisher Scientific Director of Quality Systems & Compliance - Orphazyme 
Udstyrskemiker til Aseptic Production, Equipment Team – 2 årlig stilling - ALK Trial Start-up Manager specialised in start-up activities to prepare and improve our clinical trials - Novo Nordisk 
Quality Assurance Specialist - Orifarm 
Manufacturing Scientist - FUJIFILM Diosynth Biotechnologies 
Clinical Trial Manager, Clinical Operations - Symphogen 
CMC Regulatory Affairs Manager - Bavarian Nordic 
Infrastructure Director - Genmab 
Global Pharmaceutical Expert – Europe, Regulatory Affairs - KHIDI Global Pharmaceutical Expert – Europe, Business Development & Licensing - KHIDI 
Senior Manager Business Development - Ascelia Pharma Senior Medical Writer - Orphazyme Senior contract Manager - Genmab Principal Scientist - Symphogen 
BRIDGE – Translational Excellence Programme: Call for Outstanding Postdocs and Experienced Mentors interested in Translational Medicine International Portfolio Manager - Orifarm .png)
Head of PR/Communication – MC2 Therapeutics A/S 
QA Manager - Ascendis Pharma Global Head of QA - Orphazyme Erfaren udstyrskemiker til Aseptic Production, Equipment Team - ALK Head of Staff & Project Management - Orphazyme 
CMC Specialist at VarmX BV Director of Quality Assurance Operations - Orphazyme 
Regulatory Affairs Specialist - Contura 
Experienced Scientist - LEO Pharma Brand and Marketing Manager, biomee™ – MC2 Therapeutics 
